"June 24, 2014 -- Scientists say they may be able to explain how ongoing stress raises the risk of having a heart attack.
They say stress triggers our bodies to make a surplus of disease-fighting white blood cells. That in turn can boost inf"...
Because thrombolytic therapy increases the risk of bleeding, Retavase® (reteplase) is contraindicated in the following situations:
- Active internal bleeding
- History of cerebrovascular accident
- Recent intracranial or intraspinal
- Intracranial neoplasm, arteriovenous
- Known bleeding diathesis
- Severe uncontrolled hypertension
Last reviewed on RxList: 9/15/2008
This monograph has been modified to include the generic and brand name in many instances.
Additional Retavase Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Get the latest treatment options.